John G. Ullman & Associates’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-16,866
Closed -$1.73M 151
2014
Q4
$1.73M Sell
16,866
-484
-3% -$46.4K 0.32% 78
2014
Q3
$1.5M Sell
17,350
-100
-0.6% -$8.86K 0.29% 87
2014
Q2
$1.57M Sell
17,450
-1,700
-9% -$127K 0.29% 86
2014
Q1
$1.41M Sell
19,150
-300
-2% -$20.9K 0.26% 92
2013
Q4
$1.32M Sell
19,450
-1,600
-8% -$104K 0.25% 96
2013
Q3
$1.28M Sell
21,050
-4,499
-18% -$275K 0.26% 93
2013
Q2
$1.42M Buy
+25,549
New +$1.48M 0.3% 80

John G. Ullman & Associates's COV Position: Q1 2015 in Review

John G. Ullman & Associates sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 16,866 shares — an estimated $1.73M sold.

John G. Ullman & Associates first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $1.73M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • John G. Ullman & Associates reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • John G. Ullman & Associates sold 16,866 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $1.73M.
  • John G. Ullman & Associates first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • John G. Ullman & Associates's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $1.73M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on John G. Ullman & Associates's 13F filing for Q1 2015, filed 13 May 2015.